Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivity

Caroline Benedicte Kjærulff Mathiesen

Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivity

Caroline Benedicte Kjærulff Mathiesen

Københavns Universitet

Publikation: Konferencebidrag uden forlag/tidsskrift › Poster › Formidling

Originalsprog	Engelsk
Publikationsdato	30 jan. 2018
Status	Udgivet - 30 jan. 2018
Begivenhed	Keystone Symposia: Emerging Technologies in Vaccine Discovery and Development - Banff, Canada Varighed: 28 jan. 2018 → 2 feb. 2018

Konference

Konference	Keystone Symposia
Lokation	Banff, Canada
Periode	28/01/18 → 02/02/18

Citationsformater

@conference{fdc62dc4356042a2ab1166ef022ae942,

title = "Genetically engineered cell factories produce glycoengineered vaccines that target antigen-presenting cells and reduce antigen-specific T-cell reactivity",

author = "Mathiesen, {Caroline Benedicte Kj{\ae}rulff}",

year = "2018",

month = jan,

day = "30",

language = "English",

note = "Keystone Symposia : Emerging Technologies in Vaccine Discovery and Development ; Conference date: 28-01-2018 Through 02-02-2018",

}